James Lu, M.D., Ph.D., is a chief executive officer and co-founder and at Helix, whose mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by its proprietary Exome+® assay, Helix offers health systems a scalable solution that enables the discovery of medically relevant, potentially lifesaving genetic information.
Before joining Helix, Dr. Lu was a faculty member at Duke University, where he focused on translational genomics and machine learning methodologies for electronic medical records. He has explored research topics in population genetics, Mendelian genomics, and computational psychiatry. Dr. Lu holds an M.D. and a Ph.D. from Baylor College of Medicine and a B.S. and an M.S. in chemical engineering from Stanford University.
